What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Professionals Jose Angel Jimenez Lasanta Professionals Ane López González Professionals Alba García Moral Professionals Alvaro Garcia Del campo Sóc especialista en Medicina Intensiva des de principis de 2000 quan vaig acabar la meva residència a l'Hospital Universitari Vall d'Hebron. Des d'aleshores, treballo a la Unitat de Postoperats de Cirurgia Cardíaca (UPCC) d’aquest centre, desenvolupant una activitat clínica i docent. Professionals Nuria Vallejo Camazón Professionals Pamela Patricia Yesquen Salcedo Professionals Paula Andrea Sánchez Álvarez Professionals Stephanie Tasayco Huaman Professionals Hajar Tourabi Professionals Marta Calvo Aguilar Professionals Lucia Iglesias Sanchez Professionals Clara Rey Valenzuela Professionals Miguel Del Campo Casanelles Professionals Isabel de Rojas de Pablo Professionals Liubovi Sopco International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies in children. Contact Protocol code: NCT05751044 / MH21HEM HEM-iSMART_Subprotocol D EudraCT code: No aplica Pathology: Tumors Principal investigator: Velasco Puyó, Pablo Research group: Childhood Cancer and Blood Disorders Service: Oncologia Phase: Fase II Recruiting: Closed Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies in children. Contact Protocol code: NCT05751044 / MH21HEM HEM-iSMART_Subprotocol C EudraCT code: No aplica Pathology: Tumors Principal investigator: Velasco Puyó, Pablo Research group: Childhood Cancer and Blood Disorders Service: Oncology Phase: Phase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies in children. Contact Protocol code: NCT05751044 / MH21HEM HEM-iSMART_Subprotocol B EudraCT code: No aplica Pathology: Tumors Principal investigator: Velasco Puyó, Pablo Research group: Childhood Cancer and Blood Disorders Service: Oncology Phase: Phase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Ensayo aleatorizado, doble ciego y controlado con placebo, con unafase de extension abierta, para evaluar la farmacocin~tica, la seguridad y la eficacia delos comprimidos de empagliflozina en pacientes pediatricos con enfermedad renal cr6nica(EMPA-KIDNEY® Kids). Contact Protocol code: 1245-0256 EudraCT code: No aplica Pathology: Malalties del sistema genitourinari Principal investigator: Ariceta Iraola, Gema Research group: Fisiopatologia renal Service: Nefrologia Pediàtrica Phase: Fase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio en fase IIb, multicéntrico, aleatorizado, doble ciego y controlado con placebo de tratamiento con IMVT-1402 en participantes adultos con polineuropatía desmielinizante inflamatoria crónica (PDIC). Contact Protocol code: IMVT-1402-2401 EudraCT code: No aplica Pathology: Malalties del sistema nerviós Principal investigator: Juntas Morales, Raul Research group: Peripheral Nervous System Service: Neurologia Phase: Phase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Pagination First page « Previous page ‹ … Page 300 Page 301 Current page 302 Page 303 Page 304 … Next page › Last page »
